Becton Dickinson & Co. closed 28.21% short of its 52-week high of $251.99, which the company reached on February 3rd.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the industry. The only way you can have any growth is buy it.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

In this article, you’ll find some of the top content that was published on LCGC this week, including details on the recent merger between Waters Corporation and BD Biosciences.

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...

When investors are attempting to find the best stocks to buy now, they should look beyond factors such as company size (small ...

The plaintiffs allege Dickinson’s conduct and misrepresentations led to the firm’s financial decline ...

Explore the insights of the Biopsy Devices Companies Quadrant—a comprehensive analysis of the global biopsy device market. This report evaluates over 140 companies, highlighting the top 15 leaders ...

Army Public School BD Bari inaugurated its newly developed state-of-the-art lawn tennis facility, marked by a ceremonial ...

Davenport blends dividend discipline, bond yield upside, and contrarian equity picks in DBALX. See how balanced investing ...

The Tissue Nanotransfection Market is gaining significant traction in the field of regenerative medicine due to its ...